{"content":"<li class=\"n-box-item date-title\" data-end=\"1472529599\" data-start=\"1472443200\" data-txt=\"Sunday, December 22, 2019\">Monday, August 29, 2016</li><li class=\"n-box-item sa-box-item\" data-id=\"3205963\" data-ts=\"1472510335\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OMC\" target=\"_blank\">OMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3205963-you-deserve-break-mcdonalds-splits-publicis-consolidates-omnicom\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">You deserve a break: McDonald&#39;s splits with Publicis, consolidates with Omnicom</a></h4><ul>   <li>Omnicom (NYSE:<a href='https://seekingalpha.com/symbol/OMC' title='Omnicom Group Inc.'>OMC</a>) got a boost today, <font color='green'>up 1.5%</font> as it scored a coup: <a href=\"http://www.wsj.com/articles/mcdonalds-consolidates-agency-business-with-omnicom-1472496095\" target=\"_blank\">taking control of the McDonald's account</a> after the fast food giant ended a decades-long relationship.</li>    <li>Following a review, McDonald's elected to consolidate business with Omnicom to united media and creative work, putting wraps on a 35-year relationship with Leo Burnett, part of Publicis Groupe (<a href='https://seekingalpha.com/symbol/PUBGY' title='Publicis Groupe S.A. ADR'>OTCQX:PUBGY</a>).</li>    <li>Omnicom will be working with McDonald's -- which spent $820M on U.S. advertising last year -- to build an \"agency of the future,\" says McD's Chief Marketing Officer Deborah Wahl.</li>    <li>McDonald's has had an existing creative relationship with Omnicom's DDB for 45 years.</li>    <li>And agencies may change, but taglines don't always follow suit: \"I'm Lovin' It\" will continue to be a part of McDonald's campaigns.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3205963\" data-linked=\"You deserve a break: McDonald&#39;s splits with Publicis, consolidates with Omnicom\" data-tweet=\"$OMC $OMC $PUBGY - You deserve a break: McDonald&#39;s splits with Publicis, consolidates with Omnicom https://seekingalpha.com/news/3205963-you-deserve-break-mcdonalds-splits-publicis-consolidates-omnicom?source=tweet\" data-url=\"https://seekingalpha.com/news/3205963-you-deserve-break-mcdonalds-splits-publicis-consolidates-omnicom\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:38 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3205949\" data-ts=\"1472506711\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3205949-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/CZR' title='Caesars Entertainment'>CZR</a> <font color='green'>+4.7%</font>. MCUR <font color='green'>+4.0%</font>. SPU <font color='green'>+3.6%</font>. <a href='https://seekingalpha.com/symbol/INO' title='Inovio Pharmaceuticals, Inc.'>INO</a> <font color='green'>+2.5%</font>. <a href='https://seekingalpha.com/symbol/CSTM' title='Constellium Holdco B.V.'>CSTM</a> <font color='green'>+1.8%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/SCSC' title='ScanSource, Inc.'>SCSC</a> <font color='red'>-11.5%</font>. <a href='https://seekingalpha.com/symbol/HSY' title='The Hershey Company'>HSY</a> <font color='red'>-11.4%</font>. <a href='https://seekingalpha.com/symbol/CTLT' title='Catalent'>CTLT</a> <font color='red'>-4.7%</font>. <a href='https://seekingalpha.com/symbol/NIHD' title='NII Holdings, Inc.'>NIHD</a> <font color='red'>-3.2%</font>. <a href='https://seekingalpha.com/symbol/PBT' title='Permian Basin Royalty Trust'>PBT</a> <font color='red'>-2.9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3205949\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$CZR $LPTX $FTFT - After Hours Gainers / Losers https://seekingalpha.com/news/3205949-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3205949-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:38 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3205944\" data-ts=\"1472505091\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STAF\" target=\"_blank\">STAF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3205944-staffing-360-solutions-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Staffing 360 Solutions beats on revenue</a></h4><ul>\n<li>Staffing 360 Solutions (NASDAQ:<a href=\"https://seekingalpha.com/symbol/STAF\" title=\"Staffing 360 Solutions, Inc.\">STAF</a>): FQ4 Net loss of $2.8M</li>\n<li>Revenue of $44.4M (+37.9% Y/Y) <font color=\"green\">beats by $0.09M</font>.</li>\n<li>Shares <font color=\"green\">+8%</font> AH.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3205944\" data-linked=\"Staffing 360 Solutions beats on revenue\" data-tweet=\"$STAF - Staffing 360 Solutions beats on revenue https://seekingalpha.com/news/3205944-staffing-360-solutions-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3205944-staffing-360-solutions-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3205933\" data-ts=\"1472503050\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SYRS\" target=\"_blank\">SYRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3205933-syros-pharma-scientific-founders-validate-new-drug-candidate-shares-up-19-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Syros Pharma scientific founders validate new drug candidate; shares up 19% after hours</a></h4><ul>\n<li>Recent IPO Syros Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SYRS\" title=\"Syros Pharmaceuticals\">SYRS</a>) moves ahead <font color=\"green\">19%</font> after hours, albeit on only 4,025 shares, in response to its <a href=\"http://www.businesswire.com/news/home/20160829005099/en/Syros%E2%80%99-Scientific-Founders-Publish-Selective-CDK12-CDK13\" target=\"_blank\">announcement </a>that scientific founders Nathanael Gray and Richard Young have employed a novel chemistry approach to design the first selective inhibitor of difficult-to-drug enzymes cyclin-dependent kinase 12 (CDK12) and CDK13. The chemistry method is the same one that created <a href=\"http://syros.com/pipeline/\" target=\"_blank\">SY-1365</a>, a selective CDK7 inhibitor in development for the treatment of blood cancers and others.</li>\n<li>In a <a href=\"http://www.nature.com/nchembio/journal/vaop/ncurrent/full/nchembio.2166.html\" target=\"_blank\">paper just published</a> in the journal <em>Nature Chemical Biology</em>, the scientists showed that selectively inhibiting CDK12 and CDK13 with a small molecule decreases the expression of DNA damage response genes and super-enhancer-associated transcription factors implicated in cancer, including leukemia, breast cancer and ovarian cancer. The results suggest that a selective CDK12 and CDK13 inhibitor could be effective as monotherapy in certain cancers and as part of combination therapy in other cancers by increasing the cancers' susceptibility to targeted therapies involved in DNA repair (i.e., PARP inhibitors).</li>\n<li>Syros holds all research, development and commercialization rights to the compound (THZ531) described in the paper in addition to related compounds.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3205933\" data-linked=\"Syros Pharma scientific founders validate new drug candidate; shares up 19% after hours\" data-tweet=\"$SYRS - Syros Pharma scientific founders validate new drug candidate; shares up 19% after hours https://seekingalpha.com/news/3205933-syros-pharma-scientific-founders-validate-new-drug-candidate-shares-up-19-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3205933-syros-pharma-scientific-founders-validate-new-drug-candidate-shares-up-19-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:37 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3205904\" data-ts=\"1472500127\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAB\" target=\"_blank\">CAB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3205904-speculation-picks-up-indicating-cabelas-is-in-play\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Speculation picks up indicating Cabela&#39;s is in play</a></h4><ul> <li>Shares of Cabela's (<a href=\"https://seekingalpha.com/symbol/CAB\" title=\"Cabela's Incorporated\">CAB</a> <font color=\"red\">-0.1%</font>) have broken higher from their session low amid some chatter that the company is now in talks with a PE consortium.</li>\n<li>Last month, reports indicated that Bass Pro Shops was on the verge of a deal to buy out Cabela's.</li>\n<li>Cabela's trades about 10% below its high from earlier in the summer.</li>  <li>Previously: <a href=\"https://seekingalpha.com/news/3193282-bass-pro-shops-seen-reeling-cabelas\" target=\"_blank\">Bass Pro Shops seen reeling in Cabela's</a> (July 14)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3205904\" data-linked=\"Speculation picks up indicating Cabela&#39;s is in play\" data-tweet=\"$CAB - Speculation picks up indicating Cabela&#39;s is in play https://seekingalpha.com/news/3205904-speculation-picks-up-indicating-cabelas-is-in-play?source=tweet\" data-url=\"https://seekingalpha.com/news/3205904-speculation-picks-up-indicating-cabelas-is-in-play\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3205899\" data-ts=\"1472498892\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PBR\" target=\"_blank\">PBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3205899-bloomberg-petrobras-near-6b-pipeline-sale-to-brookfield-led-group\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bloomberg: Petrobras near $6B pipeline sale to Brookfield-led group</a></h4><ul>     <li>Petrobras (<a href=\"https://seekingalpha.com/symbol/PBR\" title=\"Petrobras - Petroleo Brasileiro S.A.\">PBR</a> <font color=\"green\">+3.1%</font>) is <a href=\"http://www.bloomberg.com/news/articles/2016-08-29/petrobras-said-near-record-pipeline-sale-to-brookfield-led-group\" target=\"_blank\">in the final stages of selling</a> its Nova Transportadora do Sudeste natural gas distribution network to a group led by Brookfield Asset Management, and could sell more than a <a href=\"https://seekingalpha.com/news/3188994-bloomberg-petrobras-near-6b-sale-brazil-gas-pipeline-network\" target=\"_blank\">previously planned 81%</a>, Bloomberg reports.</li>     <li>PBR may agree on the sale of the gas pipelines and storage unit before the end of September in a deal estimated at $5.5B-$6B, according to the report.</li>     <li>\"Petrobras is desperately trying to spin off assets as it faces a mountain of debt due in 2017, 2018 and 2019,\" says analyst with the FGE consultancy group.</li>     <li>PBR also is enjoying a lift <a href=\"http://www.bloomberg.com/news/articles/2016-08-29/brazil-stocks-rise-on-recovery-bets-as-rousseff-trial-nears-end\" target=\"_blank\">along with other Brazilian stocks</a> as investors bet that Pres. Rousseff will be permanently removed from office this week.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3205899\" data-linked=\"Bloomberg: Petrobras near $6B pipeline sale to Brookfield-led group\" data-tweet=\"$PBR - Bloomberg: Petrobras near $6B pipeline sale to Brookfield-led group https://seekingalpha.com/news/3205899-bloomberg-petrobras-near-6b-pipeline-sale-to-brookfield-led-group?source=tweet\" data-url=\"https://seekingalpha.com/news/3205899-bloomberg-petrobras-near-6b-pipeline-sale-to-brookfield-led-group\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3205897\" data-ts=\"1472497576\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3205897-rousseff-takes-stand-impeachment-trial-bovespa-rallies\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rousseff takes the stand at impeachment trial; Bovespa rallies</a></h4><ul>\n<li>\u201cMy conscience is clear,\" <a href=\"http://blogs.barrons.com/emergingmarketsdaily/2016/08/29/rousseff-self-defense-watch-brazil-gdp-not-me/?mod=BOL_hp_blog_stw\" target=\"_blank\">she tells lawmakers turned judges</a>. \"I did not commit a crime.\u201d She says the impeachment process has worsened the country's recession, and calls interim President Michel Temer a \"usurper.\" Brazil, she says, would not have elected someone who picked a Cabinet of all white men in a country more than 50% non-white, she adds.</li>\n<li>The Senate votes on Rousseff's fate either tomorrow or Wednesday. Meanwhile, there's plenty of economic news coming this week, including Q2 GDP, August wholesale inflation, and government budget numbers. The central bank meets Wednesday and is expected to hold its benchmark rate steady at 14.25%.</li>\n<li>The Brazilian real (NYSEARCA:<a href=\"https://seekingalpha.com/symbol/BZF\" title=\"WisdomTree Brazilian Real ETF\">BZF</a>) continues to move higher,<font color=\"green\"> up 0.6%</font> today and <font color=\"green\">22%</font> for the year. The Bovespa is <font color=\"green\">up 1.8%</font> this session.</li>\n<li>ETFs: <a href=\"https://seekingalpha.com/symbol/EWZ\" title=\"iShares MSCI Brazil Capped ETF\">EWZ</a>, <a href=\"https://seekingalpha.com/symbol/BRF\" title=\"VanEck Vectors Brazil Small-Cap ETF\">BRF</a>, <a href=\"https://seekingalpha.com/symbol/BRZU\" title=\"Direxion Daily Brazil Bull 3x Shares ETF\">BRZU</a>, <a href=\"https://seekingalpha.com/symbol/EWZS\" title=\"iShares MSCI Brazil Small-Cap ETF\">EWZS</a>, <a href=\"https://seekingalpha.com/symbol/BZQ\" title=\"ProShares UltraShort MSCI Brazil Capped ETF\">BZQ</a>, <a href=\"https://seekingalpha.com/symbol/BRAQ\" title=\"Global X Brazil Consumer ETF\">BRAQ</a>, <a href=\"https://seekingalpha.com/symbol/BRAZ\" title=\"Global X Brazil Mid-Cap ETF\">BRAZ</a>, <a href=\"https://seekingalpha.com/symbol/UBR\" title=\"ProShares Ultra MSCI Brazil Capped ETF\">UBR</a>, <a href=\"https://seekingalpha.com/symbol/DBBR\" title=\"Deutsche X-trackers MSCI Brazil Hedged Equity ETF\">DBBR</a>, <a href=\"https://seekingalpha.com/symbol/FBZ\" title=\"First Trust Brazil AlphaDEX ETF\">FBZ</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3205897\" data-linked=\"Rousseff takes the stand at impeachment trial; Bovespa rallies\" data-tweet=\"$BZF $EWZ $BRF - Rousseff takes the stand at impeachment trial; Bovespa rallies https://seekingalpha.com/news/3205897-rousseff-takes-stand-impeachment-trial-bovespa-rallies?source=tweet\" data-url=\"https://seekingalpha.com/news/3205897-rousseff-takes-stand-impeachment-trial-bovespa-rallies\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3205895\" data-ts=\"1472497236\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3205895-technology-top-5-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/KONE' title='Kingtone Wirelessinfo Solution Holding Ltd'>KONE</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/APPS' title='Digital Turbine, Inc.'>APPS</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/NIHD' title='NII Holdings, Inc.'>NIHD</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/TRT' title='Trio-Tech International'>TRT</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/I' title='Intelsat SA'>I</a> <font color='green'>+9%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/BOSC' title='B.O.S. Better Online Solutions'>BOSC</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/NAME' title='Rightside Group, Ltd.'>NAME</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/CPSH' title='CPS Technologies Corp.'>CPSH</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/PLPM' title='Planet Payment, Inc.'>PLPM</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/AMSWA' title='American Software, Inc.'>AMSWA</a> <font color='red'>-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3205895\" data-linked=\"Technology - Top 5 Gainers / Losers as of 3:00 pm\" data-tweet=\"$KONE $APPS $NIHD - Technology - Top 5 Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3205895-technology-top-5-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3205895-technology-top-5-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3205893\" data-ts=\"1472497041\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TMUS\" target=\"_blank\">TMUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3205893-t-mobileplus-2-wells-fargo-upgrades-on-cash-flow-prospects\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">T-Mobile +2% as Wells Fargo upgrades on cash flow prospects</a></h4><ul>   <li>T-Mobile (<a href=\"https://seekingalpha.com/symbol/TMUS\" title=\"T-Mobile US, Inc.\">TMUS</a> <font color=\"green\">+2%</font>) earned an <a href=\"http://blogs.barrons.com/techtraderdaily/2016/08/29/t-mobile-wells-ups-to-buy-on-cash-flow-sprint-still-the-top-pick/\" target=\"_blank\">upgrade to Outperform</a> from Wells Fargo, with its \"primary focus\" on cash flow.</li>    <li>The carrier is approaching a \"hockey stick\" move in free cash flow generation, analyst Jennifer Fritzsche says, with no ill effect from spectrum spending in FCC auctions.</li>    <li>Wells has a $54 price target on T-Mobile, implying 15% upside from today's price.</li>    <li>She sees $1B in free cash flow in fiscal 2016, followed by $2.6B in F2017 and $3.7B in F2018. That's on a base assumption the company spends $7B on spectrum, but in her model even if the company spends $8.3B, it would still mean almost $3/share in FCF in 2017.</li>    <li>Fritzsche's top pick in the sector is still Sprint (\"We still can give a longer catalyst list for Sprint\"), though the firm expects both Sprint (<a href=\"https://seekingalpha.com/symbol/S\" title=\"Sprint Corporation\">S</a> <font color=\"green\">+1.5%</font>) and T-Mobile stock to do well based on different metrics.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3205893\" data-linked=\"T-Mobile +2% as Wells Fargo upgrades on cash flow prospects\" data-tweet=\"$TMUS $TMUS $S - T-Mobile +2% as Wells Fargo upgrades on cash flow prospects https://seekingalpha.com/news/3205893-t-mobileplus-2-wells-fargo-upgrades-on-cash-flow-prospects?source=tweet\" data-url=\"https://seekingalpha.com/news/3205893-t-mobileplus-2-wells-fargo-upgrades-on-cash-flow-prospects\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>212&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3205886\" data-ts=\"1472496950\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNAT\" target=\"_blank\">CNAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3205886-conatus-to-use-exalenz-bios-breath-test-in-nash-study-of-emricasan-shares-up-9\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Conatus to use Exalenz Bio&#39;s breath test in NASH study of emricasan; shares up 9%</a></h4><ul>\n<li>Thinly traded nano cap Conatus Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/CNAT\" title=\"Conatus Pharmaceuticals\">CNAT</a> <font color=\"green\">+8.7%</font>) is up on a 35x surge in volume. Shares peaked at almost <font color=\"green\">24%</font> before easing on the news of a <a href=\"https://www.thestreet.com/story/13687443/1/exalenz-bioscience-announces-collaboration-with-conatus-pharmaceuticals-to-use-breathid-to-monitor-patients-with-cirrhosis-associated-with-nash.html?source=sa\" target=\"_blank\">collaboration </a>with Exalenz Bioscience under which Conatus will use its <a href=\"http://www.exalenz.com/mainmenu/breathid-hp/urea-breath-test\" target=\"_blank\">BreathID Methacetin Breath Test</a> (MBT) to monitor patients in a Phase 2b clinical trial assessing lead product candidate emricasan for the treatment of patients with non-alcoholic steatohepatitis (NASH).</li>\n<li>The study, called ENCORE-PH, should commence in the coming months. Participants will receive two breath tests: the first during the screening stage and the second at Week 24. The results will be used to investigate the validity of using the BreathID MBT to quantitate improvements in liver function compared to standard tests such as HVPG (hepatic venous pressure gradient) and MELD (Model for End-Stage Liver Disease) score.</li>\n<li>Exalenz, based in Israel, currently markets a <a href=\"http://www.exalenz.com/landing-pages/breathid-hp-in-primary-care\" target=\"_blank\">breath test</a> to detect the presence of the gut bacterium <em>H. pylori.</em> The patient breaths into a nasal cannula before and after drinking a substrate. The device generates a result in 10 - 15 minutes based on the level of change in Carbon-13-labeled urea in the patient's breath.</li>\n<li>Fast Track-tagged <a href=\"http://www.conatuspharma.com/programs/\" target=\"_blank\">emricasan </a>inhibits a family of enzymes that modulate essential cellular functions called <a href=\"https://en.wikipedia.org/wiki/Caspase\" target=\"_blank\">caspases</a>. The functions include those involved in apoptosis and inflammation. Caspases 3 and 7 are major players in apoptosis. These enzymes cleave a key protein called <a href=\"https://biocare.net/wp-content/uploads/3061.pdf\" target=\"_blank\">CK18</a> (cytokeratin-18), part of which is the small fragment cCK18, which correlates to the magnitude of hepatocyte apoptosis. Emricasan inhibits apoptosis regardless of the stimuli that causes it.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3205886\" data-linked=\"Conatus to use Exalenz Bio&#39;s breath test in NASH study of emricasan; shares up 9%\" data-tweet=\"$CNAT - Conatus to use Exalenz Bio&#39;s breath test in NASH study of emricasan; shares up 9% https://seekingalpha.com/news/3205886-conatus-to-use-exalenz-bios-breath-test-in-nash-study-of-emricasan-shares-up-9?source=tweet\" data-url=\"https://seekingalpha.com/news/3205886-conatus-to-use-exalenz-bios-breath-test-in-nash-study-of-emricasan-shares-up-9\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3205891\" data-ts=\"1472496312\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CACQ\" target=\"_blank\">CACQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3205891-caesars-acquisition-falls-amid-parent-company-drama\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Caesars Acquisition falls amid parent company drama</a></h4><ul> <li>Shares of Caesars Acquisition Company (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CACQ\" title=\"Caesars Acquisition Company\">CACQ</a>) are <font color=\"red\">down 4.08%</font> to $11.51 after a judge lifts the bankruptcy shield for Caesars Entertainment.</li> <li>Caesars Acquisition fits into the Caesars puzzle through its investment and controlling vote in Caesars Growth Partners which holds a variety of casino assets.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3205784-caesars-entertainment-crushed-judge-peels-away-lawsuit-protection\" target=\"_blank\">Caesars Entertainment crushed after judge peels away lawsuit protection</a> (Aug. 29)</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3205891\" data-linked=\"Caesars Acquisition falls amid parent company drama\" data-tweet=\"$CACQ - Caesars Acquisition falls amid parent company drama https://seekingalpha.com/news/3205891-caesars-acquisition-falls-amid-parent-company-drama?source=tweet\" data-url=\"https://seekingalpha.com/news/3205891-caesars-acquisition-falls-amid-parent-company-drama\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3205887\" data-ts=\"1472495346\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APC\" target=\"_blank\">APC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3205887-anti-fracking-measures-come-up-short-for-colorado-ballot\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Anti-fracking measures come up short for Colorado ballot</a></h4><ul>     <li>Oil and natural gas explorers <a href=\"http://www.bloomberg.com/news/articles/2016-08-29/drillers-dodge-10-billion-a-year-threat-to-output-in-colorado\" target=\"_blank\">escape a vote in Colorado</a> that could have severely limited drilling in the state, as two measures that would have allowed local communities to ban hydraulic fracturing fail to garner enough support for the November ballot.</li>     <li>A proposal that would have restricted drilling near homes fell ~21K valid signatures short of the total needed to qualify for a ballot vote, and a measure allowing local governments to ban fracking also failed to attract enough signatures, <a href=\"https://content.govdelivery.com/accounts/COSOS/bulletins/160232c\" target=\"_blank\">according to</a> the Colorado Secretary of State's office.</li>     <li>Colorado's top producers include Anadarko Petroleum (<a href=\"https://seekingalpha.com/symbol/APC\" title=\"Anadarko Petroleum Corporation\">APC</a> <font color=\"green\">+1.3%</font>), Encana (<a href=\"https://seekingalpha.com/symbol/ECA\" title=\"Encana Corporation\">ECA</a> <font color=\"green\">+0.4%</font>), Noble Energy (<a href=\"https://seekingalpha.com/symbol/NBL\" title=\"Noble Energy, Inc.\">NBL</a> <font color=\"green\">+1.4%</font>), PDC Energy (<a href=\"https://seekingalpha.com/symbol/PDCE\" title=\"PDC Energy, Inc.\">PDCE</a> <font color=\"green\">+1.6%</font>), Whiting Petroleum (<a href=\"https://seekingalpha.com/symbol/WLL\" title=\"Whiting Petroleum Corporation\">WLL</a> <font color=\"green\">+1.9%</font>), Bill Barrett (BBG <font color=\"green\">+5.3%</font>), Carrizo Oil and Gas (<a href=\"https://seekingalpha.com/symbol/CRZO\" title=\"Carrizo Oil &amp; Gas, Inc.\">CRZO</a> <font color=\"green\">+2.2%</font>) and Synergy Resources (SYRG <font color=\"green\">+5.2%</font>).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3205887\" data-linked=\"Anti-fracking measures come up short for Colorado ballot\" data-tweet=\"$APC $APC $ECA - Anti-fracking measures come up short for Colorado ballot https://seekingalpha.com/news/3205887-anti-fracking-measures-come-up-short-for-colorado-ballot?source=tweet\" data-url=\"https://seekingalpha.com/news/3205887-anti-fracking-measures-come-up-short-for-colorado-ballot\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>58&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3205881\" data-ts=\"1472493874\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3205881-energy-materials-top-5-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm</a></h4><ul> <li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/CRK\" title=\"Comstock Resources Inc.\">CRK</a> <font color=\"green\">+21%</font>. <a href=\"https://seekingalpha.com/symbol/AREX\" title=\"Approach Resources Inc.\">AREX</a> <font color=\"green\">+20%</font>. <a href=\"https://seekingalpha.com/symbol/FELP\" title=\"Foresight Energy LP\">FELP</a> <font color=\"green\">+11%</font>. <a href=\"https://seekingalpha.com/symbol/CLD\" title=\"Cloud Peak Energy, Inc.\">CLD</a> <font color=\"green\">+9%</font>. <a href=\"https://seekingalpha.com/symbol/ALJ\" title=\"Alon USA Energy, Inc.\">ALJ</a> <font color=\"green\">+9%</font>.</li> <li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/NOG\" title=\"Northern Oil &amp; Gas, Inc\">NOG</a> <font color=\"red\">-8%</font>. <a href=\"https://seekingalpha.com/symbol/XCO\" title=\"EXCO Resources, Inc.\">XCO</a> <font color=\"red\">-6%</font>. <a href=\"https://seekingalpha.com/symbol/PACD\" title=\"Pacific Drilling SA\">PACD</a> <font color=\"red\">-5%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3205881\" data-linked=\"Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm\" data-tweet=\"$CRK $AREX $FELP - Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3205881-energy-materials-top-5-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3205881-energy-materials-top-5-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3205868\" data-ts=\"1472490033\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3205868-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CCCR-OLD' title='China Commercial Credit'>CCCR-OLD</a> <font color='green'>+10%</font>. WAC <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/PMTS' title='CPI Card Group'>PMTS</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/YRD' title='Yirendai LTD.'>YRD</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/GNW' title='Genworth Financial, Inc.'>GNW</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/EMITF' title='Elbit Imaging Ltd.'>EMITF</a> <font color='red'>-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3205868\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$CCCR-OLD $DHCP $PMTS - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3205868-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3205868-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3205866\" data-ts=\"1472489449\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3205866-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> MCUR <font color='green'>+95%</font>. SPU <font color='green'>+48%</font>. <a href='https://seekingalpha.com/symbol/KONE' title='Kingtone Wirelessinfo Solution Holding Ltd'>KONE</a> <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/DFBG-OLD' title='Differential Brands Group Inc.'>DFBG-OLD</a> <font color='green'>+16%</font>.<a href='https://seekingalpha.com/symbol/JYNT' title='The Joint Corp.'>JYNT</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/CCCR-OLD' title='China Commercial Credit'>CCCR-OLD</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/STAF' title='Staffing 360 Solutions, Inc.'>STAF</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/NIHD' title='NII Holdings, Inc.'>NIHD</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/CLCD' title='CoLucid Pharmaceuticals'>CLCD</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/CSTM' title='Constellium Holdco B.V.'>CSTM</a>&nbsp;<font color='green'>+12%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CZR' title='Caesars Entertainment'>CZR</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/ATRS' title='Antares Pharma Inc.'>ATRS</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/BOSC' title='B.O.S. Better Online Solutions'>BOSC</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/ADMP' title='Adamis Pharmaceuticals Corp.'>ADMP</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/CORE' title='Core-Mark Holding Company, Inc.'>CORE</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/CPSH' title='CPS Technologies Corp.'>CPSH</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/GSOL' title='Global Sources Ltd.'>GSOL</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/EGLE' title='Eagle Bulk Shipping Inc.'>EGLE</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/EMITF' title='Elbit Imaging Ltd.'>EMITF</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/PSG' title='Performance Sports Group Ltd.'>PSG</a> <font color='red'>-7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3205866\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$LPTX $FTFT $KONE - Midday Gainers / Losers https://seekingalpha.com/news/3205866-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3205866-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3205864\" data-ts=\"1472489390\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATI\" target=\"_blank\">ATI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3205864-allegheny-tech-upgraded-to-buy-deutsche-bank\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Allegheny Tech upgraded to Buy at Deutsche Bank</a></h4><ul>     <li>Allegheny Technologies (<a href=\"https://seekingalpha.com/symbol/ATI\" title=\"Allegheny Technologies Incorporated\">ATI</a> <font color=\"green\">+8.8%</font>) is on the move after Deutsche Bank <a href=\"http://thefly.com/landingPageNews.php?id=2423990&amp;headline=ATI-Allegheny-spikes-after-Deutsche-Bank-says-balance-sheet-leverage-may-improve-\" target=\"_blank\">upgrades</a> shares to Buy from Hold with a $20 price target, raised from $15, citing easing concerns over leverage following the closure of its Rowley titanium sponge facility.</li>     <li>ATI management is beginning to exit low-margin businesses and close high cost operations. which should benefit the company beginning in 2017, as the company announced several actions on Aug. 24 to improve future financial performance, which included the indefinite idling of the Rowley plant.</li>\n<li>The firm calculates that balance sheet leverage based on net debt to EBITDA could improve to 3.4x by year-end 2017 following a Q3 equity raise (20% dilution) vs. 10x in 2016.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3205864\" data-linked=\"Allegheny Tech upgraded to Buy at Deutsche Bank\" data-tweet=\"$ATI - Allegheny Tech upgraded to Buy at Deutsche Bank https://seekingalpha.com/news/3205864-allegheny-tech-upgraded-to-buy-deutsche-bank?source=tweet\" data-url=\"https://seekingalpha.com/news/3205864-allegheny-tech-upgraded-to-buy-deutsche-bank\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:49 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3205853\" data-ts=\"1472489288\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LRCX\" target=\"_blank\">LRCX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3205853-kla-tencor-now-too-interesting-to-ignore-for-cowen-and-company-upgraded-to-outperform\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KLA-Tencor &#39;now too interesting to ignore&#39; for Cowen and Company, upgraded to Outperform</a></h4><ul>\n<li>\n<a href=\"http://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Cowen+Sees+Favorable+RiskReward+in+KLA-Tencor+%28KLAC%29+and+Raises+Rating+to+Outperform/11979543.html\" target=\"_blank\">Sets</a> $80 price target (current price $68.88).</li>\n<li>Analyst Timothy Arcuri sees Lam Research (<a href=\"https://seekingalpha.com/symbol/LRCX\" title=\"Lam Research Corporation\">LRCX</a> <font color=\"green\">+1%</font>) a better investment resulting from a <a href=\"https://seekingalpha.com/news/3202170-lam-research-kla-tencor-extend-merger-timeline-shares-hit-hard\" target=\"_blank\">potential merger</a> with KLA-Tencor (<a href=\"https://seekingalpha.com/symbol/KLAC\" title=\"KLA-Tencor Corporation\">KLAC</a> <font color=\"green\">+1.9%</font>), though remains positive on the latter regardless. He cites a 3 to 1 risk to reward upside ratio with or without a deal.</li>\n<li>A finalized agreement between the companies has been anticipated since last October, though regulatory hurdles have continued to delay the process. Arcuri further attributes possible closed-door hesitancy to the Lam Research side.</li>\n<li>KLA-Tencor is <font color=\"green\">up around 30%</font> since right before (October 19, 2015) the merger was <a href=\"https://seekingalpha.com/news/2842906-lam-research-buy-kla-tencor-10_6b-deal\" target=\"_blank\">proposed</a>, with Lam Research <font color=\"green\">up around 40%</font> over the same period.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3205853\" data-linked=\"KLA-Tencor &#39;now too interesting to ignore&#39; for Cowen and Company, upgraded to Outperform\" data-tweet=\"$LRCX $LRCX $KLAC - KLA-Tencor &#39;now too interesting to ignore&#39; for Cowen and Company, upgraded to Outperform https://seekingalpha.com/news/3205853-kla-tencor-now-too-interesting-to-ignore-for-cowen-and-company-upgraded-to-outperform?source=tweet\" data-url=\"https://seekingalpha.com/news/3205853-kla-tencor-now-too-interesting-to-ignore-for-cowen-and-company-upgraded-to-outperform\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:48 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3205859\" data-ts=\"1472487770\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INO\" target=\"_blank\">INO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3205859-inovio-launches-early-phase-zika-vaccine-study-in-puerto-rico-shares-up-6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Inovio launches early-phase Zika vaccine study in Puerto Rico; shares up 6%</a></h4><ul>\n<li>Inovio Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/INO\" title=\"Inovio Pharmaceuticals, Inc.\">INO</a> <font color=\"green\">+5.8%</font>) initiates a 160-subject clinical study in Puerto Rico assessing the safety, immune responses and signals of efficacy of GLS-5700, its Zika vaccine candidate. If successful, the company plans to meet with regulators next year to clarify a development path to registration.</li>\n<li>The study is a double-blind, placebo-controlled trial under which 80 participants will receive the vaccine and 80 will receive placebo. Administration will be done with Inovio's CELLECTRA-3P, an intradermal DNA vaccine delivery device based on <a href=\"http://www.inovio.com/technology/electroporation-delivery/electroporation-devices/\" target=\"_blank\">electroporation</a>.</li>\n<li>Inovio is co-developing GLS-5700 with South Korean firm <a href=\"http://www.genels.com/en/\" target=\"_blank\">GeneOne Life Science</a>. A study in healthy U.S. and Canadian volunteers started in June.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3205859\" data-linked=\"Inovio launches early-phase Zika vaccine study in Puerto Rico; shares up 6%\" data-tweet=\"$INO - Inovio launches early-phase Zika vaccine study in Puerto Rico; shares up 6% https://seekingalpha.com/news/3205859-inovio-launches-early-phase-zika-vaccine-study-in-puerto-rico-shares-up-6?source=tweet\" data-url=\"https://seekingalpha.com/news/3205859-inovio-launches-early-phase-zika-vaccine-study-in-puerto-rico-shares-up-6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>46&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3205855\" data-ts=\"1472486430\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3205855-consumer-goods-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer Goods - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> SPU <font color='green'>+42%</font>. <a href='https://seekingalpha.com/symbol/VNCE' title='Vince Holding Corp.'>VNCE</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/DFBG-OLD' title='Differential Brands Group Inc.'>DFBG-OLD</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/SORL' title='SORL Auto Parts, Inc.'>SORL</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/WATT' title='Energous Corp.'>WATT</a> <font color='green'>+10%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3205855\" data-linked=\"Consumer Goods - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$FTFT $VNCE $DFBG-OLD - Consumer Goods - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3205855-consumer-goods-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3205855-consumer-goods-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3205843\" data-ts=\"1472483654\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TMUS\" target=\"_blank\">TMUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3205843-amid-criticism-t-mobile-boosts-upcoming-unlimited-data-plans\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amid criticism, T-Mobile boosts upcoming unlimited-data plans</a></h4><ul>   <li>Buffeted by some criticism over its <a href=\"https://seekingalpha.com/news/3204285-t-mobile-launches-70-month-unlimited-data-plan\" target=\"_blank\">all-unlimited data move</a>, T-Mobile (<a href=\"https://seekingalpha.com/symbol/TMUS\" title=\"T-Mobile US, Inc.\">TMUS</a> <font color=\"green\">+1.8%</font>) has issued changes to the new T-Mobile One plans with T-Mobile One Plus, with the plans launching five days sooner, this Thursday.</li>    <li>Following criticism of its tethering speed, T-Mobile says it's upgraded hotspot speed on its standard plan to 3G, from a planned 2G. In addition, while mainline customers will get unlimited video \"optimized\" at 480p, the company will offer HD \"day passes\" for $3/day, allowing customers to stream unlimited HD video in a 24-hour period. Those passes will arrive in October.</li>    <li>Targeted at its heavier-use customers, the T-Mobile One Plus plans will offer unlimited 4G LTE hotspot data, unlimited HD day passes, and double the speed when abroad (3G), for $25 more per line (over the $70/month for the one-line plan).</li>    <li>The quick tweaks are part of T-Mobile's \"Shut up and Listen\" approach, says CEO John Legere -- \"I\u2019ve said it before and I\u2019ll say it again \u2013 the best way to run your company is to shut up, listen to your customers, and then do what they say!\" -- but no doubt T-Mobile was also giving a listen to Sprint (<a href=\"https://seekingalpha.com/symbol/S\" title=\"Sprint Corporation\">S</a> <font color=\"green\">+0.4%</font>), which had created a <a href=\"https://seekingalpha.com/news/3205647-sprint-tweaks-unlimited-plan-option-high-def-data-eaters\" target=\"_blank\">high-end data-hungry version</a> of its unlimited plan on Friday.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3205843\" data-linked=\"Amid criticism, T-Mobile boosts upcoming unlimited-data plans\" data-tweet=\"$TMUS $TMUS $S - Amid criticism, T-Mobile boosts upcoming unlimited-data plans https://seekingalpha.com/news/3205843-amid-criticism-t-mobile-boosts-upcoming-unlimited-data-plans?source=tweet\" data-url=\"https://seekingalpha.com/news/3205843-amid-criticism-t-mobile-boosts-upcoming-unlimited-data-plans\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>38&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3205839\" data-ts=\"1472483108\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BZH\" target=\"_blank\">BZH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3205839-beazers-zelnak-buys-company-stock\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Beazer&#39;s Zelnak buys more company stock</a></h4><ul>\n<li>In his third purchase this month, Beazer Homes (<a href=\"https://seekingalpha.com/symbol/BZH\" title=\"Beazer Homes USA, Inc.\">BZH</a> <font color=\"green\">+3.1%</font>) board member Stephen Zelnak <a href=\"https://www.sec.gov/Archives/edgar/data/915840/000091584016000120/xslF345X03/wf-form4_147247559790238.xml\" target=\"_blank\">bought 13.6K shares</a> of stock on Friday at $10.50 each.</li>\n<li>Zelnak has now purchased about 86K shares of the rallying stock this month, brining his stake up to 278K.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3205101-beazer-homes-insiders-makes-2nd-buy-month\" target=\"_blank\">Beazer Homes insiders makes 2nd buy this month</a> (Aug. 24)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3205839\" data-linked=\"Beazer&#39;s Zelnak buys more company stock\" data-tweet=\"$BZH - Beazer&#39;s Zelnak buys more company stock https://seekingalpha.com/news/3205839-beazers-zelnak-buys-company-stock?source=tweet\" data-url=\"https://seekingalpha.com/news/3205839-beazers-zelnak-buys-company-stock\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3205816\" data-ts=\"1472482830\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3205816-healthcare-top-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top Gainers / Losers as of 11:00 am</a></h4><ul>     <li>\n<b>Gainers:</b> MCUR <font color=\"green\">+103%</font>. <a href=\"https://seekingalpha.com/symbol/JYNT\" title=\"The Joint Corp.\">JYNT</a> <font color=\"green\">+18%</font>. <a href=\"https://seekingalpha.com/symbol/LNTH\" title=\"Lantheus Holdings\">LNTH</a> <font color=\"green\">+13%</font>. <a href=\"https://seekingalpha.com/symbol/PRSC\" title=\"The Providence Service Corporation\">PRSC</a> <font color=\"green\">+9%</font>. <a href=\"https://seekingalpha.com/symbol/CGNT\" title=\"Cogentix Medical, Inc.\">CGNT</a> <font color=\"green\">+8%</font>.</li>\n<li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/ATRS\" title=\"Antares Pharma Inc.\">ATRS</a> <font color=\"red\">-17%</font>. <a href=\"https://seekingalpha.com/symbol/ADMP\" title=\"Adamis Pharmaceuticals Corp.\">ADMP</a> <font color=\"red\">-15%</font>. <a href=\"https://seekingalpha.com/symbol/CORI\" title=\"Corium International, Inc.\">CORI</a> <font color=\"red\">-9%</font>. <a href=\"https://seekingalpha.com/symbol/SSY\" title=\"SunLink Health Systems, Inc\">SSY</a> <font color=\"red\">-6%</font>. <a href=\"https://seekingalpha.com/symbol/TGTX\" title=\"TG Therapeutics, Inc.\">TGTX</a> <font color=\"red\">-6%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3205816\" data-linked=\"Healthcare - Top Gainers / Losers as of 11:00 am\" data-tweet=\"$LPTX $JYNT $LNTH - Healthcare - Top Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3205816-healthcare-top-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3205816-healthcare-top-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3205837\" data-ts=\"1472482618\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IVPAF\" target=\"_blank\">IVPAF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3205837-ivanhoe-mines-to-seek-strategic-adviser-following-unsolicited-interest\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ivanhoe Mines to seek strategic adviser following unsolicited interest</a></h4><ul>     <li>Ivanhoe Mines (<a href=\"https://seekingalpha.com/symbol/IVPAF\" title=\"Ivanhoe Mines Ltd.\">OTCQX:IVPAF</a> <font color=\"green\">+13.1%</font>) says it plans to hire a strategic adviser to <a href=\"http://business.financialpost.com/news/mining/ivanhoe-mines-hires-bankers-after-receiving-unsolicited-interest-for-company-projects\" target=\"_blank\">address unsolicited interest</a> received in recent months after a major copper discovery in Africa earlier this year.</li>     <li>Ivanhoe does not identify the parties that have expressed interest, beyond saying that the inquiries are from \u201csignificant mining industry participants in Asia, Europe, Africa and elsewhere.\u201d</li>     <li>Ivanhoe's Kakula discovery is part of the company\u2019s Kamoa copper project, which is  thought to be the world\u2019s largest untouched high-grade copper  discovery.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3205837\" data-linked=\"Ivanhoe Mines to seek strategic adviser following unsolicited interest\" data-tweet=\"$IVPAF - Ivanhoe Mines to seek strategic adviser following unsolicited interest https://seekingalpha.com/news/3205837-ivanhoe-mines-to-seek-strategic-adviser-following-unsolicited-interest?source=tweet\" data-url=\"https://seekingalpha.com/news/3205837-ivanhoe-mines-to-seek-strategic-adviser-following-unsolicited-interest\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3205836\" data-ts=\"1472482508\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LPTX\" target=\"_blank\">LPTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3205836-macrocure-up-102-on-merger-leap-therapeutics\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Macrocure up 102% on merger with Leap Therapeutics</a></h4><ul>\n<li>Thinly traded nano cap Macrocure (MCUR <font color=\"green\">+101.7%</font>) doubles on a 25x surge in volume in response to its announcement that it will merge with privately held Leap Therapeutics and will become its subsidiary. Leap intends to apply to Nasdaq for listing there.</li>\n<li>Under the terms of the deal, Macrocure stockholders will exchange their shares for newly issued Leap common shares. Existing Leap investors, including affiliates of HealthCare Ventures, will invest an additional $10M in the combined firm, which will have at least $30M in quick assets going forward. Leap equity holders will own ~68.2% of the business while Macrocure equity holders will own 31.8%.</li>\n<li>The combined firm's pipeline includes DKN-01, a monoclonal antibody that binds to the Dickkopf-1 protein, in development for the treatment of esophageal cancer and cholangiocarcinoma and TRX518, a humanized aglycosyl IgG1 monoclonal antibody that is believed to enhance the immune system's anti-tumor response.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3205836\" data-linked=\"Macrocure up 102% on merger with Leap Therapeutics\" data-tweet=\"$LPTX - Macrocure up 102% on merger with Leap Therapeutics https://seekingalpha.com/news/3205836-macrocure-up-102-on-merger-leap-therapeutics?source=tweet\" data-url=\"https://seekingalpha.com/news/3205836-macrocure-up-102-on-merger-leap-therapeutics\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3205829\" data-ts=\"1472481065\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TAYD\" target=\"_blank\">TAYD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3205829-taylor-devices-reports-fq4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Taylor Devices reports FQ4 results</a></h4><ul>\n<li>Taylor Devices (NASDAQ:<a href=\"https://seekingalpha.com/symbol/TAYD\" title=\"Taylor Devices, Inc.\">TAYD</a>): FQ4 EPS of $0.31 vs. $0.26 in 4Q15</li>\n<li>Revenue of $9.06M (-15.9% Y/Y)</li>\n<li>Shares <font color=\"green\">+2.6%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3205829\" data-linked=\"Taylor Devices reports FQ4 results\" data-tweet=\"$TAYD - Taylor Devices reports FQ4 results https://seekingalpha.com/news/3205829-taylor-devices-reports-fq4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3205829-taylor-devices-reports-fq4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:31 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3205828\" data-ts=\"1472480817\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HGEN\" target=\"_blank\">HGEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3205828-shkreli-unloads-kalobios-stake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shkreli unloads KaloBios stake</a></h4><ul>\n<li>In a <a href=\"https://www.sec.gov/Archives/edgar/data/1293310/000114420416121613/v447889_ex99-1.htm\" target=\"_blank\">statement</a>, KaloBios Pharmaceuticals (KBIO <font color=\"green\">+7.1%</font>) says former CEO Martin Shkreli has sold his entire stake in the firm to other investors in private transactions.</li>\n<li>The company continues its turnaround efforts. It emerged from Chapter 11 bankruptcy on June 30 with $14M in equity financing and the rights to develop antiparasitic drug benznidazole for Chagas disease. A Phase 1 study of product candidate lenzilumab in chronic myelomonocytic leukemia is underway as well.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3205828\" data-linked=\"Shkreli unloads KaloBios stake\" data-tweet=\"$HGEN - Shkreli unloads KaloBios stake https://seekingalpha.com/news/3205828-shkreli-unloads-kalobios-stake?source=tweet\" data-url=\"https://seekingalpha.com/news/3205828-shkreli-unloads-kalobios-stake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3205827\" data-ts=\"1472480699\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KS\" target=\"_blank\">KS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3205827-kapstone-paper-and-packaging-stays-on-hot-run\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KapStone Paper and Packaging stays on a hot run</a></h4><ul> <li>Bank of America Merrill Lynch <a href=\"http://www.streetinsider.com/Upgrades/BofAMerrill+Lynch+Upgrades+KapStone+Paper+%26+Packaging+%28KS%29+to+Neutral/11979603.html\" target=\"_blank\">upgrades</a> KapStone Paper &amp; Packaging (<a href=\"https://seekingalpha.com/symbol/KS\" title=\"KapStone Paper and Packaging Corporation\">KS</a> <font color=\"green\">+2.6%</font>) to a Neutral rating after having the paper stock rated at Underperform,</li> <li>Last week, a favorable view on pricing trends gave the whole paper sector a boost.</li> <li>Shares of KapStone are now up over 12% over the last three sessions to force BAML into its capitulation.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3205449-paper-stocks-perk-higher-pricing-coming-road\" target=\"_blank\">Paper stocks perk up with higher pricing coming down the road</a> (Aug. 25)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3205827\" data-linked=\"KapStone Paper and Packaging stays on a hot run\" data-tweet=\"$KS - KapStone Paper and Packaging stays on a hot run https://seekingalpha.com/news/3205827-kapstone-paper-and-packaging-stays-on-hot-run?source=tweet\" data-url=\"https://seekingalpha.com/news/3205827-kapstone-paper-and-packaging-stays-on-hot-run\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3205815\" data-ts=\"1472478663\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBL\" target=\"_blank\">CBL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3205815-cbl-associates-on-move-after-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CBL &amp; Associates on the move after upgrade</a></h4><ul>\n<li>Too cheap to ignore, says Jefferies of CBL &amp; Associates (<a href=\"https://seekingalpha.com/symbol/CBL\" title=\"CBL &amp; Associates Properties, Inc.\">CBL</a> <font color=\"green\">+5.1%</font>), as it <a href=\"http://www.streetinsider.com/Analyst+Comments/Jefferies+Upgrades+CBL+%26+Associates+%28CBL%29+to+Buy%3B+Too+Cheap+To+Ignore/11979581.html\" target=\"_blank\">upgrades to Buy</a> from Hold.</li>\n<li>The price target of $16.50 is up from $10.50 previously, and suggests 25% upside from last week's close.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3205815\" data-linked=\"CBL &amp; Associates on the move after upgrade\" data-tweet=\"$CBL - CBL &amp; Associates on the move after upgrade https://seekingalpha.com/news/3205815-cbl-associates-on-move-after-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3205815-cbl-associates-on-move-after-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3205805\" data-ts=\"1472476402\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3205805-premarket-gainers-losers-of-9-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers as of 9:10 am</a></h4><ul> <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/TNXP' title='Tonix Pharmaceuticals Holding Corp.'>TNXP</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/CANF' title='Can-Fite Biopharma Ltd'>CANF</a> <font color='green'>+6%</font>.</li> <li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CZR' title='Caesars Entertainment'>CZR</a> <font color='red'>-30%</font>. <a href='https://seekingalpha.com/symbol/ADMP' title='Adamis Pharmaceuticals Corp.'>ADMP</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/BOSC' title='B.O.S. Better Online Solutions'>BOSC</a> <font color='red'>-7%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3205805\" data-linked=\"Premarket Gainers / Losers as of 9:10 am\" data-tweet=\"$TNXP $CANF $CZR - Premarket Gainers / Losers as of 9:10 am https://seekingalpha.com/news/3205805-premarket-gainers-losers-of-9-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3205805-premarket-gainers-losers-of-9-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3205800\" data-ts=\"1472475772\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TNXP\" target=\"_blank\">TNXP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3205800-tonix-pharma-up-16-premarket-on-advancement-on-tnxminus-102-sl-in-ptsd\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tonix Pharma up 16% premarket on advancement on TNX-102 SL in PTSD</a></h4><ul>\n<li>Thinly traded nano cap Tonix Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/TNXP\" title=\"Tonix Pharmaceuticals Holding Corp.\">TNXP</a>) is up <font color=\"green\">16%</font> premarket on robust volume in response to its announcement of a clear path to registration for TNX-102 SL (cyclobenzaprine HCl sublingual tablets) for the treatment of post-traumatic stress disorder (PTSD).</li>\n<li>Based on the written minutes received from the FDA from its End-of-Phase 2/Pre-Phase 3 meeting, the agency confirmed that positive results from two Phase 3 trials along with safety studies should be sufficient to demonstrate efficacy for PTSD. One Phase 3 will focus on military PTSD and the other in civilian PTSD. The former should commence in Q1 2017 and the latter will follow a bit later. The primary efficacy endpoints will be the same at the <a href=\"https://clinicaltrials.gov/ct2/show/NCT02277704?term=atease&amp;rank=1\" target=\"_blank\">AtEase</a> Phase 2: the mean change from baseline in the severity of PTSD symptoms at Week 12 as measured by a scale called CAPS-5.</li>\n<li>In addition, the FDA agreed that the company's CMC (chemistry, manufacturing and controls) and nonclinical studies it previously accepted for the fibromyalgia NDA will be valid for the NDA for PTSD.</li>\n<li>\n<a href=\"https://en.wikipedia.org/wiki/Cyclobenzaprine\" target=\"_blank\">Cyclobenzaprine</a>, branded as <a href=\"http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/017821s045lbl.pdf\" target=\"_blank\">Flexeril</a>, was cleared by the FDA in August, 1977 for the treatment of muscle spasms. The value proposition of the sublingual formulation is decreased exposure, due to avoidance of first-pass metabolism, to the active metabolite norcylcobenzaprine, less desirable due to its long plasma half-life. The proposed trade name of the product is Tonmya.</li>\n<li>Read now <a href=\"https://seekingalpha.com/article/4002468-tonixs-findings-patient-subgroups-can-mislead-investors-can-tell-real\" target=\"_blank\">Tonix's Findings About Patient Subgroups Can Mislead: How Investors Can Tell What's Real </a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3205800\" data-linked=\"Tonix Pharma up 16% premarket on advancement on TNX-102 SL in PTSD\" data-tweet=\"$TNXP - Tonix Pharma up 16% premarket on advancement on TNX-102 SL in PTSD https://seekingalpha.com/news/3205800-tonix-pharma-up-16-premarket-on-advancement-on-tnxminus-102-sl-in-ptsd?source=tweet\" data-url=\"https://seekingalpha.com/news/3205800-tonix-pharma-up-16-premarket-on-advancement-on-tnxminus-102-sl-in-ptsd\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3205795\" data-ts=\"1472475014\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HOG\" target=\"_blank\">HOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3205795-longbow-research-sees-potholes-for-harley-davidson\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Longbow Research sees potholes for Harley-Davidson</a></h4><ul> <li>Shares of Harley-Davidson (NYSE:<a href=\"https://seekingalpha.com/symbol/HOG\" title=\"Harley-Davidson, Inc.\">HOG</a>) are on watch after Longbow Research <a href=\"http://www.streetinsider.com/Downgrades/Longbow+Research+Downgrades+Harley-Davidson+%28HOG%29+to+Underperform/11979528.html\" target=\"_blank\">sets</a> estimates lower on the motorcycle seller.</li> <li>Longbow downshifts to an Underperform rating from Neutral and gives HOG a price target of $40.</li> <li>HOG <font color=\"red\">-2.97%</font> premarket to $51.01 vs. a 52-week trading range of $36.36 to $57.33.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3205795\" data-linked=\"Longbow Research sees potholes for Harley-Davidson\" data-tweet=\"$HOG - Longbow Research sees potholes for Harley-Davidson https://seekingalpha.com/news/3205795-longbow-research-sees-potholes-for-harley-davidson?source=tweet\" data-url=\"https://seekingalpha.com/news/3205795-longbow-research-sees-potholes-for-harley-davidson\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3205784\" data-ts=\"1472473571\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3205784-caesars-entertainment-crushed-after-judge-peels-away-lawsuit-protection\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Caesars Entertainment crushed after judge peels away lawsuit protection</a></h4><ul> <li>Shares of Caesars Entertainment fall back hard after a judge <a href=\"http://www.bloomberg.com/news/articles/2016-08-26/caesars-must-face-judgment-in-bondholder-lawsuits-court-rules\" target=\"_blank\">rules</a> the company must face lawsuits from bondholders.</li> <li>Caesars has been asking for a shield against the bankruptcy of its operating unit.</li> <li>Judge Benjamin Goldgar also ruled against an injunction to give the operating unit more time to secure a settlement with holdout creditors. The decision also increases the pressure on PE firms TPG and Apollo Global Management to kick in more settlement funds.</li> <li>CZR <font color=\"red\">-21.51%</font> premarket to $5.91.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3205784\" data-linked=\"Caesars Entertainment crushed after judge peels away lawsuit protection\" data-tweet=\"Caesars Entertainment crushed after judge peels away lawsuit protection https://seekingalpha.com/news/3205784-caesars-entertainment-crushed-after-judge-peels-away-lawsuit-protection?source=tweet\" data-url=\"https://seekingalpha.com/news/3205784-caesars-entertainment-crushed-after-judge-peels-away-lawsuit-protection\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3205782\" data-ts=\"1472473343\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MU\" target=\"_blank\">MU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3205782-micron-price-target-lifted-deutsche-stifel\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Micron price target lifted at Deutsche, Stifel</a></h4><ul>\n<li>A nice move continues for Micron Technology (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MU\" title=\"Micron Technology Inc.\">MU</a>) following <a href=\"https://seekingalpha.com/news/3205418-micron-technology-plus-6-percent-western-digital-plus-3-percent-following-hp-component\" target=\"_blank\">HP's results late</a> last week, as Deutsche raises its price target to $20 from $16, and Stifel to $18 from $15.</li>\n<li>\"Amid a recovery in DRAM, we are taking an in-depth look at normalized operating margin, which strongly correlates with price-to-book,\" <a href=\"http://www.streetinsider.com/Analyst+Comments/Micron+%28MU%29+PT+Raised+to+%2420+at+Nomura+on+Normalized+Margins+and+Share+Price/11972197.html\" target=\"_blank\">says Deutsche's Romit Shah</a>. \"Our analysis indicates fair value of $20 per share based on operating margin of 10%.\"</li>\n<li>Shares <font color=\"green\">+2.1%</font> premarket to $16.85.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3205782\" data-linked=\"Micron price target lifted at Deutsche, Stifel\" data-tweet=\"$MU - Micron price target lifted at Deutsche, Stifel https://seekingalpha.com/news/3205782-micron-price-target-lifted-deutsche-stifel?source=tweet\" data-url=\"https://seekingalpha.com/news/3205782-micron-price-target-lifted-deutsche-stifel\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3205753\" data-ts=\"1472470997\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SQ\" target=\"_blank\">SQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3205753-bull-on-square-heads-to-sidelines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bull on Square heads to the sidelines</a></h4><ul>\n<li>This summer's rally from $9 to $12 leaves the stock fairly valued, <a href=\"http://researchwiseny.btig.com/ResearchLibraryAnalec/DownloadResearch.aspx?E=egfjk-b\" target=\"_blank\">says BTIG's Mark Palmer</a>, downgrading Square (NYSE:<a href=\"https://seekingalpha.com/symbol/SQ\" title=\"Square, Inc.\">SQ</a>) to Neutral from Buy, and pulling his $12 price target.</li>\n<li>Palmer notes the company's Q2 report released on Aug. 3 was an impressive one - showing strong revenue and total payment volume growth, and the achievement of positive adjusted EBITDA ahead of schedule. In addition, Square Capital answered questions about its future funding with the announcement of five new investors in its platform.</li>\n<li>Shares <font color=\"red\">-1.65% </font>premarket to $11.84.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3205753\" data-linked=\"Bull on Square heads to the sidelines\" data-tweet=\"$SQ - Bull on Square heads to the sidelines https://seekingalpha.com/news/3205753-bull-on-square-heads-to-sidelines?source=tweet\" data-url=\"https://seekingalpha.com/news/3205753-bull-on-square-heads-to-sidelines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:43 AM </div></div></li>","count":34,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}